van Kleef E M, Smits J F, Schwartz S M, Daemen M J
Department of Pathology, University of Limburg, The Netherlands.
Cardiovasc Res. 1996 Feb;31(2):324-30. doi: 10.1016/0008-6363(95)00216-2.
Infusion of angiotensin II (AngII) during the third and fourth week after balloon injury of the left common carotid artery of the rat induces smooth muscle cell (SMC) DNA synthesis. In this study we wanted to investigate whether alpha 1-adrenoreceptors are involved in AngII-induced SMC DNA synthesis in the neointima.
Adult male Wistar Kyoto rats were subcutaneously infused for 2 weeks with AngII and the alpha 1-adrenoreceptor antagonist doxazosin during the 3rd and the 4th week after balloon injury of the left common carotid artery. Control groups received AngII, 0.9% NaCl, AngII + 50% dimethylsulfoxide (DMSO, the solvent of doxazosin), doxazosin or 50% dimethylsulfoxide. Each rat received 5-bromo-2'-deoxyuridine in a separate osmotic minipump to label DNA-synthesizing SMC. Systolic blood pressures were measured in all groups.
Angiotensin II caused an increase in systolic blood pressure, whereas addition of doxazosin did not affect the increase in SBP caused by AngII. In the media of the non-injured carotid artery, AngII increased SMC DNA synthesis, as the BrdUrd labeling fraction increased from 0.2 +/- 0.1% (mean +/- s.e.m.) in the NaCl group towards 3.4 +/- 0.6% in the AngII group. Coinfusion with doxazosin reduced the AngII-induced increase in BrdUrd labeling fraction from 3.2 +/- 0.8% in the AngII + DMSO group towards 0.6 +/- 0.2% in the AngII+doxazosin group. A similar effect of doxazosin was found in the media of the injured left carotid artery, in which coinfusion with doxazosin also reduced the BrdUrd labeling fraction from 2.6 +/- 0.8% in the AngII+DMSO group towards 0.3 +/- 0.1% in the AngII+doxazosin group. In the neointima of the injured left carotid artery, AngII increased the BrdUrd labeling fraction from 11.7 +/- 1.6% in the NaCl group towards 28.0 +/- 3.4% in the AngII group. Coinfusion with doxazosin did not influence the AngII-induced SMC DNA synthesis, since the BrdUrd labeling fraction in the neointima of the AngII+doxazosin group was 22.5 +/- 2.9%, whereas the neointimal BrdUrd labeling fraction in the AngII+DMSO group was 22.9 +/- 2.3%. Little effect was found on the medial cross-sectional area. The neointimal cross-sectional area was increased as a result of infusion of AngII (0.12 +/- 0.01 mm2 vs. 0.18 +/- 0.01 mm2), and coinfusion of doxazosin did not reduce the AngII-induced increase in neointimal cross-sectional area (0.18 +/- 0.03 mm2).
These data suggest that alpha 1-adrenoreceptors are not involved in AngII-induced neointimal SMC DNA synthesis and cross-sectional area, but only play a role in the media of the carotid artery.
在大鼠左颈总动脉球囊损伤后的第三和第四周输注血管紧张素II(AngII)可诱导平滑肌细胞(SMC)DNA合成。在本研究中,我们想探究α1 -肾上腺素能受体是否参与AngII诱导的新生内膜SMC DNA合成。
成年雄性Wistar Kyoto大鼠在左颈总动脉球囊损伤后的第3周和第4周皮下输注AngII以及α1 -肾上腺素能受体拮抗剂多沙唑嗪,持续2周。对照组接受AngII、0.9%氯化钠、AngII + 50%二甲基亚砜(DMSO,多沙唑嗪的溶剂)、多沙唑嗪或50%二甲基亚砜。每只大鼠通过单独的渗透微型泵接受5-溴-2'-脱氧尿苷以标记DNA合成的SMC。测量所有组的收缩压。
血管紧张素II导致收缩压升高,而添加多沙唑嗪并不影响AngII引起的收缩压升高。在未损伤的颈动脉中膜,AngII增加了SMC DNA合成,因为BrdUrd标记分数从氯化钠组的0.2±0.1%(平均值±标准误)增加到AngII组的3.4±0.6%。与多沙唑嗪共同输注将AngII诱导的BrdUrd标记分数增加从AngII + DMSO组的3.2±0.8%降低到AngII +多沙唑嗪组的0.6±0.2%。在损伤的左颈动脉中膜发现了多沙唑嗪的类似作用,与多沙唑嗪共同输注也将BrdUrd标记分数从AngII + DMSO组的2.6±0.8%降低到AngII +多沙唑嗪组的0.3±0.1%。在损伤的左颈动脉新生内膜中,AngII将BrdUrd标记分数从氯化钠组的11.7±1.6%增加到AngII组的28.0±3.4%。与多沙唑嗪共同输注并不影响AngII诱导的SMC DNA合成,因为AngII +多沙唑嗪组新生内膜中的BrdUrd标记分数为22.5±2.9%,而AngII + DMSO组新生内膜中的BrdUrd标记分数为22.9±2.3%。对中膜横截面积影响较小。由于输注AngII,新生内膜横截面积增加(0.12±0.01平方毫米对0.18±0.01平方毫米),而与多沙唑嗪共同输注并未降低AngII诱导的新生内膜横截面积增加(0.18±0.03平方毫米)。
这些数据表明α1 -肾上腺素能受体不参与AngII诱导的新生内膜SMC DNA合成和横截面积增加,而仅在颈动脉中膜起作用。